Cardiovascular Institute and Fuwai Hospital

Beijing 100037

2 studies enrolling now · 7 studies all time

What they study most

Atrial Fibrillation, Chronic Kidney Disease, Heart Failure, Pulmonary Arterial Hypertension, Stroke

Studies at this site

• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• FUTURE 3 Study Extension — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed